Towards Healthcare
U.S. Home Infusion Therapy Market to Advance 39.57 Bn by 2035

U.S. Home Infusion Therapy Market Advancing Patient Care and Outcomes

The U.S. home infusion therapy industry is projected to rise from USD 19.56 billion in 2025 to USD 36.88 billion by 2035, reflecting a CAGR of 7.3% over the next decade. Home infusion therapy in the U.S. lets patients receive medications like antibiotics, pain management, or nutrition through an IV at home instead of a hospital. It’s a convenient, cost-effective option for chronic conditions, reducing hospital stays while ensuring safe, professional care from nurses or pharmacists.

Last Updated : 31 December 2025 Category: Therapeutic Area Insight Code: 5102 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global U.S. Home Infusion Therapy Market Assessment

  • Overview
  • Global U.S. Home Infusion Therapy Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Infusion Pump
      • Elastomeric
      • Electrochemical
      • Gravity
      • Others
    • Intravenous Sets
    • IV Cannulas
    • Needless Connectors
    • Others
  • Global U.S. Home Infusion Therapy Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Anti-Infective Therapy
    • Enteral Nutrition
    • Parenteral Nutrition
    • Chemotherapy
    • Hydration Therapy
    • Chronic Diseases
    • Speciality Pharmaceuticals

Company Profiles

  • Option Care Health, Inc.
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • B. Braun Medical, Inc.
  • Baxter International Inc.
  • Fresenius Kabi USA
  • Amedisys, Inc.
  • CareCentrix, Inc.
  • ICU Medical
  • Smiths Medical, Inc.
  • CareFusion
  • Caesarea Medical Electronics Ltd.

Conclusion & Recommendations

FAQ's

Answer : The market is projected to grow from USD 19.56 billion in 2025 to USD 39.57 billion by 2035, expanding at a steady CAGR of 7.3%.

Answer : Rising chronic diseases, aging population, patient preference for home care, technological advances in infusion devices and cost savings over hospital stays are fueling market growth.

Answer : Infusion pumps dominate the market due to their essential role in medication delivery, portability, smart safety features and widespread use in home-based care.

Answer : World Health Organization, National Home Infusion Foundation, Center for Disease Control and Prevention, American Cancer Society, ScienceDirect Publication.
Any Questions

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar